業績

2025,Mukaida A, Maeda H. A cross-sectional study on the first-in-human trials of anticancer drugs in Japan and the United States and the probability of approval. Int J Clin Oncol. 2025 Aug 6. doi: 10.1007/s10147-025-02849-4.

https://link.springer.com/article/10.1007/s10147-025-02849-4